2	Gonorrhea	Q	1	HL7	MADPH				Cases are defined as meeting any of following:\nPROCID|PROCCODE|PROCEDURENAME|COMPONENTNAME|CPTCODE|COMPONENT|LOINC\n2268||GC/CHLAM DNA PROBE||LA0219||23908-7\n2268||GC/CHLAM DNA PROBE|GC GENPROBE DNA|LA0219|1311|23908-7\n2268|LA0219|GC/CHLAM DNA PROBE||LA0219||23908-7\n2268|LA0219|GC/CHLAM DNA PROBE|GC GENPROBE DNA|LA0219|1311|23908-7\n2277|87178B|GC GENPROBE DNA||87178||23908-7\n2277|87178B|GC GENPROBE DNA|GC GENPROBE DNA|87178|1311|23908-7\n314972|87591|GC GENPROBE DNA||87591||23908-7\n314972|87591|GC GENPROBE DNA|GC GENPROBE DNA|87591|1311|23908-7\n323098|87800|GC CHLAM DNA PROBE||87800||23908-7\n323098|87800|GC CHLAM DNA PROBE|GC GENPROBE DNA|87800|1311|23908-7\n323162|87800A|GC CHLAM DNA PROBE||87800||23908-7\n323162|87800A|GC CHLAM DNA PROBE|GC GENPROBE DNA|87800|1311|23908-7\n323162|87800A|GC CHLAM DNA PROBE|GC GENPROBE DNA|87800|2177|23908-7\n324601|87591B|PEDIATRIC URINE GC & CHLAM|PEDIATRIC URINE GC|87591|2488|21416-3\n324603|87591A|PEDIATRIC URINE GC||87591||21416-3\n324603|87591A|PEDIATRIC URINE GC|PEDIATRIC URINE GC|87591|2488|21416-3\n325335|87591C|GC DNA, GENITAL|N. GONORRHOEAE URN|87591|2910|21416-3\n325351|87591D|GC DNA, URINE|N. GONORRHOEAE URN|87591|2910|21416-3
3	PID	AR	1	HL7	MADPH				Cases are defined as meeting both of following:\n\n1. Positive laboratory test for Gonorrhea or Chlamydia\n2. One of the following ICD9 codes within 30 days prior to the positive lab test or in the subsequent 30 days following the positive lab test:<br> 614.0: acute salpingitis and oophoritis<br>614.2: salpingitis and oophoritis not specified as acute, subacute or chronic<br>614.3: acute parametritis and pelvic cellulites<br>614.5: acute or unspecified pelvic peritonitis, female<br>614.9: PID, unspecified<br>099.56: Chlamydia trachomatis infection of peritoneum
1	Chlamydia	Q	1	HL7	MADPH				Cases are defined as meeting any of following:\nLOINC|Component|System|Method Type|Result\n6345-3|Chlamydia sp Ag|Genital|Enzyme immunoassay|POSITIVE or DETECTED\n6346-1|Chlamydia sp Ag|Genital|Immune fluorescence|POSITIVE or DETECTED\n32671-0|Chlamydia sp Ag|Genital.Vaginal|[Method not specified]|POSITIVE or DETECTED\n32774-2|Chlamydia sp DNA|Genital|Probe.Amplification.Target|POSITIVE or DETECTED\n34708-8|Chlamydia sp DNA|Urine|Probe.Amplification.Target|POSITIVE or DETECTED\n557-9|Chlamydia sp identified|Genital|Culture.Organism specific|POSITIVE or DETECTED\n559-5|Chlamydia sp identified|Urethra|Culture.Organism specific|POSITIVE or DETECTED\n14463-4|Chlamydia trachomatis|Cervix|Culture.Organism specific|POSITIVE or DETECTED\n14464-2|Chlamydia trachomatis|Genital.Vaginal|Culture.Organism specific|POSITIVE or DETECTED\n14466-7|Chlamydia trachomatis|Penis|Culture.Organism specific|POSITIVE or DETECTED\n14465-9|Chlamydia trachomatis|Urethra|Culture.Organism specific|POSITIVE or DETECTED\n14467-5|Chlamydia trachomatis|Urine sediment|Culture.Organism specific|POSITIVE or DETECTED\n14470-9|Chlamydia trachomatis Ag|Cervix|Enzyme immunoassay|POSITIVE or DETECTED\n14509-4|Chlamydia trachomatis Ag|Cervix|Immune fluorescence|POSITIVE or DETECTED\n14471-7|Chlamydia trachomatis Ag|Genital.Vaginal|Enzyme immunoassay|POSITIVE or DETECTED\n14510-2|Chlamydia trachomatis Ag|Genital.Vaginal|Immune fluorescence|POSITIVE or DETECTED\n34709-6|Chlamydia trachomatis Ag|Nasopharynx|[Method not specified]|POSITIVE or DETECTED\n14473-3|Chlamydia trachomatis Ag|Penis|Enzyme immunoassay|POSITIVE or DETECTED\n14512-8|Chlamydia trachomatis Ag|Penis|Immune fluorescence|POSITIVE or DETECTED\n34710-4|Chlamydia trachomatis Ag|Rec|[Method not specified]|POSITIVE or DETECTED\n14472-5|Chlamydia trachomatis Ag|Urethra|Enzyme immunoassay|POSITIVE or DETECTED\n14511-0|Chlamydia trachomatis Ag|Urethra|Immune fluorescence|POSITIVE or DETECTED\n14474-1|Chlamydia trachomatis Ag|Urine sediment|Enzyme immunoassay|POSITIVE or DETECTED\n14513-6|Chlamydia trachomatis Ag|Urine sediment|Immune fluorescence|POSITIVE or DETECTED*\n21189-6|Chlamydia trachomatis DNA|Cervical mucus|Probe.Amplification.Target|POSITIVE or DETECTED*\n21190-4|Chlamydia trachomatis DNA|Cervix|Probe.Amplification.Target|POSITIVE or DETECTED*\n23838-6|Chlamydia trachomatis DNA|Fluid.Genital|Probe|POSITIVE or DETECTED*\n16600-9|Chlamydia trachomatis DNA|Genital|Probe|POSITIVE or DETECTED*\n6356-0|Chlamydia trachomatis DNA|Genital|Probe.Amplification.Target|POSITIVE or DETECTED*\n21191-2|Chlamydia trachomatis DNA|Urethra|Probe.Amplification.Target|POSITIVE or DETECTED*\n21192-0|Chlamydia trachomatis DNA|Urethra|Probe|POSITIVE or DETECTED*\n16601-7|Chlamydia trachomatis DNA|Urine|Probe|POSITIVE or DETECTED*\n6357-8|Chlamydia trachomatis DNA|Urine|Probe.Amplification.Target|POSITIVE or DETECTED*\n16602-5|Chlamydia trachomatis rRNA|Urine|Probe|POSITIVE or DETECTED*
6	Acute Hepatitis C	AR	1	HL7	MADPH				
7	Chronic Hepatitis B	AR	0	HL7	MADPH				
4	Acute Hepatitis B	AR	1	HL7	MADPH				Cases are defined as following:\n\n1. ICD9 = 782.4 (jaundice, not of newborn)\n2. Alanine aminotransferase (ALT) >132<br><table border=0 width=60%><tr><th>Component Name</th><th>CPT</th><th>Comp</th><th>LOINC</th><th>LOINC Name</th></tr><tr><td>SGPT (ALT)</td><td>80053</td><td>58</td><td>1742-6</td><td>ALT SerPl-cCnc</td></tr><tr><td>SGPT (ALT)</td><td>80076</td><td>58</td><td>1742-6</td><td>ALT SerPl-cCnc</td></tr><tr><td>SGPT (ALT)</td><td>82947</td><td>58</td><td>1742-6</td><td>ALT SerPl-cCnc</td><tr><tr><td>ALT (SGPT)</td><td>84460</td><td>1728</td><td>1742-6</td><td>ALT SerPl-cCnc</td></tr><tr><td>SGPT (ALT)</td><td>84460</td><td>58</td><td>1742-6</td><td>ALT SerPl-cCnc</td></tr><tr><td>SGPT (ALT)</td><td>85048</td><td>58</td><td>1742-6</td><td>ALT SerPl-cCnc</td></tr></table>\n3. Aspartate aminotransferase (AST) > 132<br><table border=0 width=60%><tr><th>Component Name</th><th>CPT</th><th>Comp</th><th>LOINC</th><th>LOINC Name</th></tr><tr><td>SGOT (AST)</td><td>80053</td><td>57</td><td>1920-8</td><td>AST SerPl-cCnc</td></tr><tr><td>SGOT (AST)</td><td>80076</td><td> 57</td><td>1920-8</td><td>AST SerPl-cCnc</td></tr><tr><td>SGOT (AST)</td><td>82947</td><td>57</td><td>1920-8</td><td>AST SerPl-cCnc</td></tr><tr><td>SGOT (AST)</td><td>84450</td><td>1792</td><td>1920-8</td><td>AST SerPl-cCnc</td></tr><tr><td>SGOT (AST)</td><td>84450</td><td>57</td><td>1920-8</td><td>AST SerPl-cCnc</td></tr><tr><td>SGOT (AST)</td><td>84455</td><td>57</td><td>1920-8</td><td>AST SerPl-cCnc</td></tr></table>\n4. IgM antibody to Hepatitis B Core Antigen = REACTIVE (may be truncated)<br><table border=0 width=80%><tr><th>Component Name</th><th>CPT</th><th>Comp</th><th>LOINC</th><th>LOINC Name</th></tr><tr><td>HEP B CORE (IGM) AB</td><td>80074</td><td>4330</td><td>31204-1</td><td>Hepatitis B virus core Ab.IgM : ACnc : Pt : Ser : Ord :</td></tr><tr><td>HEP B CORE (IGM) AB</td><td>86705</td><td>4330</td><td>31204-1</td><td>Hepatitis B virus core Ab.IgM : ACnc : Pt : Ser : Ord :</td></tr></table>\n5. Hepatitis B Surface Antigen = REACTIVE (may be truncated)<br><table border=0 width=80%><tr><th>Component Name</th><th>CPT</th><th>Comp</th><th>LOINC</th><th>LOINC Name</th></tr><tr><td>HEPAT B SURFACE AG </td><td>80055</td><td>223</td><td>5195-3</td><td>Hepatitis B virus surface Ag : ACnc : Pt : Ser : Ord :</td></tr><tr><td>HEPAT B SURFACE AG</td><td>80074</td><td>223</td><td>5195-3</td><td>Hepatitis B virus surface Ag : ACnc : Pt : Ser : Ord :</td></tr><tr><td>HEPAT B SURFACE AG</td><td>87340</td><td>223</td><td>5195-3</td><td>Hepatitis B virus surface Ag : ACnc : Pt : Ser : Ord :</td></tr></table>\n6.  Hepatitis B e Antigen =REACTIVE (may be truncated)<br><table border=0 width=80%><tr><th>Component Name</th><th>CPT</th><th>Comp</th><th>LOINC</th><th>LOINC Name</th></tr><tr><td>HEPATITIS BE ANTIGEN, SERUM</td><td>87350</td><td>3566</td><td>13954-3</td><td>Hepatitis B virus little e Ag : ACnc : Pt : Ser : Ord : EIA</td></tr><tr><td>HEPATITIS BE AG</td><td>87350</td><td>481</td><td>13954-3</td><td>Hepatitis B virus little e Ag : ACnc : Pt : Ser : Ord : EIA</td></tr></table>\n7.  Hepatitis B Viral DNA <br><table border=0 width=80%><tr><th>Component Name</th><th>CPT</th><th>Comp</th><th>LOINC</th><th>LOINC Name</th><th>Positive result</th></tr><tr><td>HEP B DNA PCR (QL)</td><td>83898</td><td>1667</td><td>13126-8</td><td>Hepatitis B virus DNA : ACnc : Pt : Bld : Ord : IB</td><td>POSITIVE/DETECTED</td></tr><tr><td>HEP B VIRAL DNA IU/ML </td><td>87517</td><td>2413</td><td>5009-6</td><td>Hepatitis B virus DNA : ACnc : Pt : xxx : Ord : Probe.Amp.Tar</td><td> >100</td></tr><tr><td>HEP B DNA COPIES/ML</td><td>87517</td><td>2414</td><td>5009-6</td><td>Hepatitis B virus DNA : ACnc : Pt : xxx : Ord : Probe.Amp.Tar</td><td> >160</td></tr></table>\nII.  Definitions for Positive Cases:<br>a) (1 or 2 or 3) and #4 within 14 day period<br>b) (1 or 2 or 3) and #5 reactive within 14 day period AND no prior positive result for #5 within the past 12 months<br>c) (1 or 2 or 3) and #7 positive within 14 day period AND no prior positive result for #5 or #7 within the past 12 months\nIII.  Notes:<br>Only report each patient the first time they meet the case definition, repeat positive testing suggests chronic rather than acute disease and should not be reported as acute Hepatitis B.<br>
5	Acute Hepatitis A	AR	1	HL7	MADPH				
8	Active Tuberculosis	AR	1	HL7	MADPH				
9	Active Hepatitis B in Pregnancy	AR	0	HL7	MADPH				
